EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prognostic values of tumor size and location in early stage endometrial cancer patients who received radiotherapy

Shuning Jiao iD, Lichun Wei iD, Lijuan Zou iD, Tiejun Wang iD, Ke Hu iD, Fuquan Zhang iD, Xiaorong Hou iD

Journal of Gynecologic Oncology · 2024

DOI: 10.3802/jgo.2024.35.e84 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2024. Verfasst von Shuning Jiao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Peking Union Medical College Hospital Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, …. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Neoplasm Staging, Nomograms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National High Level Hospital Clinical Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To investigate the correlation between tumor size, tumor location, and prognosis in patients with early-stage endometrial cancer (EC) receiving adjuvant radiotherapy. METHODS: Data of patients who had been treated for stage I-II EC from March 1999 to September 2017 in 13 tertiary hospitals in China was screened. Cox regression analysis was performed to investigate associations between tumor size, tumor location, and other clinical or pathological factors with cancer-specific survival (CSS) and distant metastasis failure-free survival (DMFS). The relationship between tumor size as a continuous variable and prognosis was demonstrated by restricted cubic splines. Prognostic models were constructed as nomograms and evaluated by Harrell's C-index, calibration curves and receiver operating characteristic (ROC) curves. RESULTS: The study cohort comprised 805 patients with a median follow-up of 61 months and a median tumor size of 3.0 cm (range 0.2-15.0 cm). Lower uterine segment involvement (LUSI) was found in 243 patients (30.2%). Tumor size and LUSI were identified to be independent prognostic factors for CSS. Further, tumor size was an independent predictor of DMFS. A broadly positive relationship between poor survival and tumor size as a continuous variable was visualized in terms of hazard ratios. Nomograms constructed and evaluated for CSS and DMFS had satisfactory calibration curves and C-indexes of 0.847 and 0.716, respectively. The area under the ROC curves for 3- and 5-year ROC ranged from 0.718 to 0.890. CONCLUSION: Tumor size and LUSI are independent prognostic factors in early-stage EC patients who have received radiotherapy. Integrating these variables into prognostic models would improve predictive ability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsNeoplasm StagingNomogramsHumansFemaleMiddle AgedPrognosisAgedRadiotherapy, AdjuvantAdultTumor BurdenRetrospective StudiesChinaAged, 80 and overROC Curve

Stichwörter der Autor:innen

Endometrial NeoplasmsNeoplasm StagingRadiotherapySurvival

Autor:innen und Institutionen

  • Department of Radiation Oncology, Peking Union Medical College Hospital Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China.
  • Eight-Year Medical Doctor Program, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China.
  • Department of Radiation Oncology, Xijing Hospital, Air Force Medical University of PLA (the Fourth Military Medical University), Xi'an, People's Republic of China.
  • Department of Radiation Oncology, The Second Hospital of Dalian Medical University, Dalian, People's Republic of China.
  • Department of Radiation Oncology, The Second Hospital Affiliated by Jilin University, Changchun, People's Republic of China.
  • Department of Radiation Oncology, Peking Union Medical College Hospital Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China. hxr_pumch@163.com.

ORCID-Profile: Shuning Jiao, Lichun Wei, Lijuan Zou, Tiejun Wang, Ke Hu, Fuquan Zhang, Xiaorong Hou

Förderung

  • National High Level Hospital Clinical Research Funding

Zitieren

APA

Jiao, S., Wei, L., Zou, L., Wang, T., Hu, K., Zhang, F., & Hou, X. (2024). Prognostic values of tumor size and location in early stage endometrial cancer patients who received radiotherapy. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2024.35.e84

Vancouver

Jiao S, Wei L, Zou L, Wang T, Hu K, Zhang F, et al. Prognostic values of tumor size and location in early stage endometrial cancer patients who received radiotherapy. Journal of Gynecologic Oncology. 2024. doi:10.3802/jgo.2024.35.e84

BibTeX
@article{Jiao2024,
  author = {Jiao, Shuning and Wei, Lichun and Zou, Lijuan and Wang, Tiejun and Hu, Ke and Zhang, Fuquan and Hou, Xiaorong},
  title = {Prognostic values of tumor size and location in early stage endometrial cancer patients who received radiotherapy},
  journal = {Journal of Gynecologic Oncology},
  year = {2024},
  doi = {10.3802/jgo.2024.35.e84}
}
Kostenlos starten →